Home

MATTHEW SIROVICH

CIK 1431208 · last filed 2020-11-27

MATTHEW SIROVICH is a corporate insider who has filed 29 SEC Form 4 insider transactions across 6 companies since 2008. The most recent filing shows the insider sold $170.9K of PAVMZ on Nov 27, 2020. Across all open-market trades the lifetime net is −$44.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $594.6M across reported positions. 109 SEC filings were submitted jointly with JEREMY MINDICH.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$594.59M

Companies

6

Total Filings

29

Lifetime Open-Market Net

-$44.06M

Filer Profile

Reported Address
C/O SCOPIA MANAGEMENT INC
450 SEVENTH AVENUE, 43RD FLOOR
NEW YORK, NY 10123
Related Filers
JEREMY MINDICH — 109 joint filings, latest 2019-05-30
SCOPIA CAPITAL MANAGEMENT LP — 109 joint filings, latest 2019-05-30
Scopia Management, Inc. — 85 joint filings, latest 2019-05-30
PAVmed Inc. — 11 joint filings, latest 2021-10-06
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PAVmed Inc. (PAVMZ) Delisted 10%+ Owner 2,966,041 $0.00 $2.7K -$755.6K 5 2020-11-27
ITRI 10%+ Owner 4,878,384 $97.01 $473.25M $45.05M 11 2019-05-23
Acorda Therapeutics, Inc. (ACOR) Delisted 10%+ Owner 42,826 $0.66 $28.3K -$89.77M 10 2019-01-11
Barzel Industries Inc. (TONSW) Delisted 10%+ Owner 2,573,409 — — $5.5K 1 2008-10-03
CENT 10%+ Owner 2,909,080 $41.71 $121.34M $437.4K 1 2008-04-23
SOURCE INTERLINK COMPANIES INC (SORC) Delisted 10%+ Owner 5,421,076 — — $963.7K 1 2008-04-02

Recent Filings

29 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2020-11-27 PAVmed Inc. (PAVMZ) Delisted Sell (S) −86,239 -$170.9K EDGAR
2020-11-20 PAVmed Inc. (PAVMZ) Delisted Sell (S) −100,000 -$181.6K EDGAR
2020-06-01 PAVmed Inc. (PAVMZ) Delisted Sell (S) −200,921 -$403.1K EDGAR
2020-02-03 PAVmed Inc. (PAVMZ) Delisted Exer (X) +1,199,383 $12.0K EDGAR
2019-05-23 ITRI — — $0 EDGAR
2019-03-13 ITRI Mixed −837,400 -$12.34M EDGAR
2019-01-28 PAVmed Inc. (PAVMZ) Delisted Other (J) +332,400 $0 EDGAR
2019-01-11 Acorda Therapeutics, Inc. (ACOR) Delisted Sell (S) −649,964 -$11.17M EDGAR
2018-12-26 Acorda Therapeutics, Inc. (ACOR) Delisted Sell (S) −162,024 -$2.14M EDGAR
2018-12-13 Acorda Therapeutics, Inc. (ACOR) Delisted Sell (S) −1,200,000 -$19.56M EDGAR
Showing 1–10 of 29
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.